Edgewise Therapeutics financial statements

에지와이즈 테라퓨틱스NASDAQ:EWTX · Nasdaq · Healthcare · sector #16
$40.02-0.69%
2026-10-06 close · prelim

Edgewise Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$159M.

Reported results

Edgewise Therapeutics notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q